Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma.
K L KurzinskiC K ZiglerKathryn S TorokPublished in: The British journal of dermatology (2018)
Assessment of patients with LS experiencing a relapse of disease activity has shown older age of initial LS onset and ANA positivity to be potential markers for risk of relapse. Patients meeting these parameters may require greater clinical vigilance. The presence of one or more ECM may be protective. Clinicians treating patients with LS should provide significant long-term follow-up to monitor for relapse.
Keyphrases
- disease activity
- free survival
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- ejection fraction
- rheumatoid arthritis patients
- ankylosing spondylitis
- chronic kidney disease
- newly diagnosed
- emergency department
- systemic sclerosis
- intensive care unit
- physical activity
- prognostic factors
- palliative care
- juvenile idiopathic arthritis
- peritoneal dialysis
- interstitial lung disease
- patient reported outcomes
- community dwelling